BIT
PCRX icon

BlackRock Institutional Trust’s Pacira BioSciences PCRX Stock Holding History

BlackRock Institutional Trust’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$30.8M Buy
953,623
+9,689
+1% +$323K ﹤0.01% 1649
2016
Q3 		$32.3M Buy
943,934
+39,713
+4% +$1.56M 0.01% 1564
2016
Q2 		$30.5M Sell
904,221
-4,426
-0.5% -$218K 0.01% 1563
2016
Q1 		$48.1M Buy
908,647
+5,903
+0.7% +$345K 0.01% 1247
2015
Q4 		$69.3M Buy
902,744
+15,798
+2% +$895K 0.01% 1047
2015
Q3 		$36.5M Buy
886,946
+8,662
+1% +$531K 0.01% 1427
2015
Q2 		$62.1M Sell
878,284
-186,681
-18% -$14.7M 0.01% 1177
2015
Q1 		$94.6M Buy
1,064,965
+137,039
+15% +$13.9M 0.01% 962
2014
Q4 		$82.3M Sell
927,926
-6,262
-0.7% -$592K 0.01% 989
2014
Q3 		$90.5M Sell
934,188
-44,170
-5% -$4.3M 0.02% 910
2014
Q2 		$89.9M Buy
978,358
+80,794
+9% +$6.15M 0.01% 953
2014
Q1 		$62.8M Buy
897,564
+31,471
+4% +$2.14M 0.01% 1142
2013
Q4 		$49.8M Buy
866,093
+425,266
+96% +$22.4M 0.01% 1260
2013
Q3 		$21.2M Buy
440,827
+63,186
+17% +$2.3M ﹤0.01% 1814
2013
Q2 		$11M Buy
+377,641
New +$10.9M ﹤0.01% 2246

Other funds holding PCRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
DCM
Daruma Capital Management New York $879M AUM 2.11% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

BlackRock Institutional Trust's PCRX Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Pacira BioSciences (PCRX) stake by 1% in Q4 2016, buying an estimated $323K and bringing the position to 953,623 shares worth $30.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1649.

BlackRock Institutional Trust first reported a position in PCRX in Q2 2013 and has held it in 15 quarters since. The position peaked at $94.6M in Q1 2015. 182 funds tracked by Wall St. Rank hold PCRX as of Q4 2016.

  • BlackRock Institutional Trust held 953,623 shares of Pacira BioSciences worth $30.8M as of Q4 2016.
  • BlackRock Institutional Trust bought 9,689 Pacira BioSciences shares in Q4 2016, an estimated $323K.
  • Pacira BioSciences made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #1649 holding.
  • BlackRock Institutional Trust first reported a position in Pacira BioSciences in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Institutional Trust's Pacira BioSciences position peaked at $94.6M in Q1 2015.
  • 182 funds tracked by Wall St. Rank held Pacira BioSciences as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.